Search Results - Yu. N. Gorbunova

Refine Results
  1. 1
    Adipocytokines in early rheumatoid arthritis: relationship to pro- and anti-inflammatory markers

    Adipocytokines in early rheumatoid arthritis: relationship to pro- and anti-inflammatory markers by L. V. Kondratyeva, T. V. Popkova, Yu. N. Gorbunova

    Published 2019-01-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Hyperleptinemia as a marker of various phenotypes of obesity and overweight in women with rheumatoid arthritis and systemic lupus erythematosus

    Hyperleptinemia as a marker of various phenotypes of obesity and overweight in women with rheumatoid arthritis and systemic lupus erythematosus by L. V. Kondrateva, Yu. N. Gorbunova, T. A. Panafidina, T. V. Popkova

    Published 2023-06-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Obesity and overweight phenotypes in patients with systemic lupus erythematosus based on body mass index and serum leptin levels: a pilot cross-sectional study

    Obesity and overweight phenotypes in patients with systemic lupus erythematosus based on body mass index and serum leptin levels: a pilot cross-sectional study by L. V. Kondratyeva, T. V. Popkova, T. A. Panafidina, Yu. N. Gorbunova

    Published 2022-07-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Subclinical myocardial dysfunction of the left ventricular in patients with systemic lupus erythematosus

    Subclinical myocardial dysfunction of the left ventricular in patients with systemic lupus erythematosus by R. A. Karateev, I. G. Kirillova, Yu. N. Gorbunova, T. V. Popkova

    Published 2024-12-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Clinical significance of leptin in systemic lupus erythematosus

    Clinical significance of leptin in systemic lupus erythematosus by L. V. Kondratyeva, T. A. Panafidina, T. V. Popkova, Yu. N. Gorbunova, M. V. Cherkasova

    Published 2021-12-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Subclinical left ventricular dysfunction and N-terminal pro-brain natriuretic peptide in patients with rheumatoid arthritis

    Subclinical left ventricular dysfunction and N-terminal pro-brain natriuretic peptide in patients with rheumatoid arthritis by I. G. Kirillova, Yu. N. Gorbunova, T. V. Popkova, M. E. Diatroptov, E. L. Nasonov

    Published 2022-11-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    The level of soluble receptor of 33 sST2 and subclinical myocardial dysfunction in patients with systemic lupus erythematosus

    The level of soluble receptor of 33 sST2 and subclinical myocardial dysfunction in patients with systemic lupus erythematosus by R. A. Karateev, T. V. Popkova, I. G. Kirillova, Yu. N. Gorbunova, M. E. Diatroptov

    Published 2025-05-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Dynamics of global longitudinal strain of the left ventricular myocardium and blood biomarker levels in patients with rheumatoid arthritis treated with biologic disease-modifying antirheumatic drugs or Janus kinase inhibitors

    Dynamics of global longitudinal strain of the left ventricular myocardium and blood biomarker levels in patients with rheumatoid arthritis treated with biologic disease-modifying a... by Yu. N. Gorbunova, I. G. Kirillova, T. V. Popkova, M. E. Diatroptov, T. I. Nevretdinov, A. M. Lila

    Published 2023-10-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Diabetes mellitus and hyperglycemia in patients with rheumatoid arthritis

    Diabetes mellitus and hyperglycemia in patients with rheumatoid arthritis by L. V. Kondratyeva, T. A. Panafidina, E. V. Gerasimova, Yu. N. Gorbunova, T. V. Popkova, E. L. Nasonov

    Published 2014-09-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Dynamics of body composition indicators in patients with early rheumatoid arthritis during therapy with methotrexate and biological drugs (pilot study)

    Dynamics of body composition indicators in patients with early rheumatoid arthritis during therapy with methotrexate and biological drugs (pilot study) by Yu. N. Gorbunova, L. V. Kondratyeva, T. V. Popkova, N. V. Demin, A. V. Smirnov, E. L. Nasonov

    Published 2024-11-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Body composition in patients with early rheumatoid arthritis

    Body composition in patients with early rheumatoid arthritis by Yu. N. Gorbunova, L. V. Kondratyeva, T. V. Popkova, N. V. Demin, A. V. Smirnov, E. L. Nasonov

    Published 2021-03-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Dynamics of T- and B-lymphocytes in patients with rheumatoid arthritis, receiving biological disease-modifying antirheumatic drugs

    Dynamics of T- and B-lymphocytes in patients with rheumatoid arthritis, receiving biological disease-modifying antirheumatic drugs by A. V. Martynova, T. V. Popkova, A. P. Aleksankin, G. I. Gridneva, E. V. Gerasimova, Yu. N. Gorbunova, A. M. Lila

    Published 2022-02-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Effect of interleukin 6 blockers on body composition, adipocytokines and insulin-like growth factor 1 in patients with rheumatoid arthritis

    Effect of interleukin 6 blockers on body composition, adipocytokines and insulin-like growth factor 1 in patients with rheumatoid arthritis by L. V. Kondratyeva, Yu. N. Gorbunova, T. V. Popkova, A. A. Abramkin, T. A. Lisitsyna, N. V. Demin, M. E. Diatroptov, A. S. Avdeeva

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    Clinical significance of interferon status in patients with systemic lupus erythematosus. Preliminary data

    Clinical significance of interferon status in patients with systemic lupus erythematosus. Preliminary data by T. A. Panafidina, T. V. Popkova, Yu. N. Gorbunova, L. V. Kondratyeva, E. V. Tchetina, A. S. Avdeeva, A. M. Lila, E. L. Nasonov

    Published 2025-03-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    Chronic Heart Failure in Early Rheumatoid Arthritis Patients Prior to Basic Antirheumatic Therapy

    Chronic Heart Failure in Early Rheumatoid Arthritis Patients Prior to Basic Antirheumatic Therapy by I. G. Kirillova, D. S. Novikova, T. V. Popkova, H. V. Udachkina, E. I. Markelova, Yu. N. Gorbunova, Yu. O. Korsakova, S. N. Gluchova

    Published 2020-03-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    T- and B-lymphocytes subpopulations in the early and advanced rheumatoid arthritis

    T- and B-lymphocytes subpopulations in the early and advanced rheumatoid arthritis by A. V. Martynova, T. V. Popkova, A. P. Aleksankin, G. I. Gridneva, E. V. Gerasimova, Yu. N. Gorbunova, A. S. Semashko, A. M. Lila

    Published 2021-04-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    Immunophenotypes of systemic lupus erythematosus – features of clinical and laboratory disorders

    Immunophenotypes of systemic lupus erythematosus – features of clinical and laboratory disorders by Anastasia S. Avdeeva, Andrey P. Aleksankin, Elena V. Tchetina, Yu. N. Gorbunova, Tatiana V. Popkova, Galina A. Markova, Tatiana A. Panafidina, Evgeny L. Nasonov

    Published 2024-09-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    DNA double-strand breaks in immunoinflammatory rheumatic diseases

    DNA double-strand breaks in immunoinflammatory rheumatic diseases by A. S. Avdeeva, A. P. Aleksankin, Zh. G. Verizhnikova, V. V. Rybakova, M. E. Diatroptov, Yu. N. Gorbunova, A. A. Mesnyankina, D. A. Paranich, A. M. Lila, E. L. Nasonov

    Published 2023-08-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    CARDIOVASCULAR RISK IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS BEFORE DISEASE-MODIFYING ANTIRHEUMATIC THERAPY (PRELIMINARY DATA OF THE REMARCА STUDY)

    CARDIOVASCULAR RISK IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS BEFORE DISEASE-MODIFYING ANTIRHEUMATIC THERAPY (PRELIMINARY DATA OF THE REMARCА STUDY) by Yu. N. Gorbunova, D. S. Novikova, T. V. Popkova, E. I. Markelova, Yu. O. Korsakova, O. A. Fomicheva, D. S. Kolmakova, E. L. Luchikhina, D. E. Karateev, A. V. Smirnov, E. L. Nasonov

    Published 2014-09-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    IMPACT OF ANTIRHEUMATIC THERAPY ON THE LEVEL OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS

    IMPACT OF ANTIRHEUMATIC THERAPY ON THE LEVEL OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS by I. G. Kirillova, D. S. Novikova, T. V. Popkova, E. V. Udachkina, E. I. Markelova, A. A. Novikov, Yu. N. Gorbunova, A. V. Volkov, E. L. Luchikhina, N. V. Demidova, M. A. Borisova, G. V. Lukina

    Published 2018-07-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: